Skip to main content
Clinical Trials/NCT03181542
NCT03181542CompletedNot Applicable

A Randomized Controlled Study of Efficacy of Infra Red Vein Illumination Versus Standard Technique

Milton S. Hershey Medical Center1 site in 1 country160 target enrollmentStarted: July 10, 2017Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
160
Locations
1
Primary Endpoint
Success Rate

Study Overview

Brief Summary

The objective of the study is to assess the efficacy of the vein visualization device AccuVein (AccuVein, Inc., Huntington, NY) in comparison to a standard technique for establishing intravenous (iv) access in the infant and toddler population (<2years)

Detailed Description

The objective of this project is to compare the iv success rate using the FDA approved Accuvein device for vein illumination versus not using the device, for infants/toddlers undergoing surgery at Penn State Children's Hospital with an ASA physical status 1, 2, or 3. After obtaining informed consent, the infant will be randomized to the vein illuminatin or standard group based on a computer generated number.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Supportive Care
Masking
None

Eligibility Criteria

Ages
— to 2 Years (Child)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Children(<2year) undergoing anesthesia procedures at Penn State Health, Hershey Medical Center and Penn State Children's Hospital
  • •ASA physical status 1,2 or 3

Exclusion Criteria

  • •Emergency procedures requiring anesthesia
  • •ASA physical status 4
  • •Patients with pre existing iv access

Arms & Interventions

Infrared vein illumination

Experimental

Infrared illumination of veins, using the FDA approved AccuVein device, will be used to assist in vein location when inserting an intravenous access line

Intervention: Infrared illumination (Device)

Standard Technique

No Intervention

Standard vein location techniques will be used when inserting an intravenous access line

Outcomes

Primary Outcomes

Success Rate

Time Frame: When patient is in operating room and insertion of intravenous access line has been confirmed to be successful, an average of 30 minutes

Success for insertion of intravenous access line will be determined by flushability with 5 ml of sterile normal saline

Secondary Outcomes

  • Time to Successful Insertion(When patient is in operating room and insertion of intravenous access line is performed)
  • The Number of Attempts(When patient is in operating room and insertion of intravenous access line is performed)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Priti G. Dalal

Professor of Anesthesiology & Perioperative Medicine

Milton S. Hershey Medical Center

Study Sites (1)

Loading locations...

Similar Trials